These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The effect of taurolidine on experimental thrombus formation. Kaptanoglu L, Kucuk HF, Colak E, Kurt N, Bingul SM, Akyol H, Torlak OA, Yazici F. Eur J Pharmacol; 2008 Jan 14; 578(2-3):238-41. PubMed ID: 17961549 [Abstract] [Full Text] [Related]
3. Effects of delayed administration of octreotide in acute experimental pancreatitis. Kaplan O, Kaplan D, Casif E, Siegal A, Paran H, Graf E, Skornick Y. J Surg Res; 1996 Apr 14; 62(1):109-17. PubMed ID: 8606496 [Abstract] [Full Text] [Related]
7. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis. Tarhan OR, Barut I, Sezik M. J Surg Res; 2008 Jan 14; 144(1):151-7. PubMed ID: 17981298 [Abstract] [Full Text] [Related]
9. Effect of the somatostatin analogue octreotide on experimental pancreatitis in rats. Paran H, Klausner J, Siegal A, Graff E, Freund U, Kaplan O. J Surg Res; 1996 May 14; 62(2):201-6. PubMed ID: 8632640 [Abstract] [Full Text] [Related]
19. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma. Nici L, Monfils B, Calabresi P. Clin Cancer Res; 2004 Nov 15; 10(22):7655-61. PubMed ID: 15569998 [Abstract] [Full Text] [Related]